Research Progress of Spironolactone as an Antagonist of NRG1-ERBB4 Pathway in the Treatment of Cognitive Impairment in Schizophrenia. Issue 6 (6th January 2020)

Record Type:: Journal Article
Title:: Research Progress of Spironolactone as an Antagonist of NRG1-ERBB4 Pathway in the Treatment of Cognitive Impairment in Schizophrenia. Issue 6 (6th January 2020)
Main Title:: Research Progress of Spironolactone as an Antagonist of NRG1-ERBB4 Pathway in the Treatment of Cognitive Impairment in Schizophrenia
Authors:: Zhang, Hongwei
Dai, Zunxiao
Lin, Huali
Tian, Ruiping
Zhu, Jing
Is Part Of:: International journal of clinical and medical cases. Volume 3:Issue 6(2020)
Journal:: International journal of clinical and medical cases
Issue:: Volume 3:Issue 6(2020)
Issue Display:: Volume 3, Issue 6 (2020)
Year:: 2020
Volume:: 3
Issue:: 6
Issue Sort Value:: 2020-0003-0006-0000
Page Start:
Page End:
Publication Date:: 2020-01-06
Subjects:: Clinical medicine -- Case studies
Internal medicine -- Case studies
616.09
Journal URLs:: https://www.boffinaccess.com/journals/clinical-and-medical-cases/current-issue.php ↗
DOI:: ↗
Languages:: English
ISSNs:: 2517-7346
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library HMNTS - ELD Digital store
Ingest File:: 14391.xml